Lihui Wang

684 total citations
34 papers, 407 citations indexed

About

Lihui Wang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Lihui Wang has authored 34 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Lihui Wang's work include Angiogenesis and VEGF in Cancer (6 papers), MicroRNA in disease regulation (4 papers) and Cancer-related gene regulation (4 papers). Lihui Wang is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), MicroRNA in disease regulation (4 papers) and Cancer-related gene regulation (4 papers). Lihui Wang collaborates with scholars based in China, United States and Germany. Lihui Wang's co-authors include Qin Zhuang, Zhaoquan Huang, Jin Dai, Xueyun Zhong, Wei Mao, Li Ma, Jing Gao, Liya Zhou, Ying He and Xiaoming Xu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Lihui Wang

29 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lihui Wang China 13 279 109 64 55 49 34 407
Chengwu Zhang China 12 245 0.9× 143 1.3× 61 1.0× 94 1.7× 39 0.8× 28 459
Alessandro Barberis Italy 13 199 0.7× 111 1.0× 74 1.2× 39 0.7× 35 0.7× 23 460
Monika Buríková Slovakia 13 262 0.9× 109 1.0× 115 1.8× 100 1.8× 54 1.1× 14 461
Dain Kim South Korea 7 203 0.7× 126 1.2× 57 0.9× 71 1.3× 18 0.4× 18 391
Qisheng Luo China 12 380 1.4× 207 1.9× 58 0.9× 44 0.8× 29 0.6× 43 538
H-S Hsu Taiwan 6 228 0.8× 120 1.1× 125 2.0× 50 0.9× 43 0.9× 6 441
Zhengwei Leng China 12 287 1.0× 146 1.3× 140 2.2× 78 1.4× 40 0.8× 26 555
Jasdeep Chhina United States 8 244 0.9× 159 1.5× 93 1.5× 45 0.8× 31 0.6× 12 429

Countries citing papers authored by Lihui Wang

Since Specialization
Citations

This map shows the geographic impact of Lihui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihui Wang more than expected).

Fields of papers citing papers by Lihui Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihui Wang. The network helps show where Lihui Wang may publish in the future.

Co-authorship network of co-authors of Lihui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lihui Wang. A scholar is included among the top collaborators of Lihui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihui Wang. Lihui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Lulu, Lihui Wang, Jun Lin, et al.. (2025). Dihydroartemisinin targets ANXA2 to suppress hepatocellular carcinoma angiogenesis through the PI3K/AKT signaling pathway. Tissue and Cell. 97. 103087–103087.
2.
3.
Wang, Lihui, et al.. (2024). Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway. Molecular Cancer Research. 22(7). 668–681. 3 indexed citations
4.
Wang, Lihui, et al.. (2024). Vasorin promotes endothelial differentiation of glioma stem cells via stimulating the transcription of VEGFR2. The FASEB Journal. 38(10). e23682–e23682. 2 indexed citations
5.
Li, Pei-Wen, Tianyu Wang, Qianyu Chen, et al.. (2023). Activated KRAS reprograms neural progenitor cells to glioma stem cell‑like phenotype. International Journal of Oncology. 63(1). 2 indexed citations
6.
7.
Wang, Lihui, et al.. (2021). RNF168 suppresses the cancer stem cell‐like traits of nonsmall cell lung cancer cells by mediating RhoC ubiquitination. Environmental Toxicology. 37(3). 603–611. 4 indexed citations
8.
9.
Su, Wenmei, Chunfang Guo, Lihui Wang, et al.. (2019). LncRNA MIR22HG abrogation inhibits proliferation and induces apoptosis in esophageal adenocarcinoma cells via activation of the STAT3/c-Myc/FAK signaling. Aging. 11(13). 4587–4596. 36 indexed citations
10.
Ye, Pei, Hui Sun, Jun Lin, et al.. (2018). Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma. Biomedicine & Pharmacotherapy. 101. 219–227. 19 indexed citations
11.
Su, Zhenghui, Yanqi Zhang, Baojian Liao, et al.. (2018). Antagonism between the transcription factors NANOG and OTX2 specifies rostral or caudal cell fate during neural patterning transition. Journal of Biological Chemistry. 293(12). 4445–4455. 17 indexed citations
12.
Zhang, Yong, et al.. (2017). UHRF1 is an Independent Prognostic Factor and a Potential Therapeutic Target of Esophageal Squamous Cell Carcinoma. Journal of Cancer. 8(19). 4027–4039. 11 indexed citations
13.
Wang, Lihui, Xirui Li, Wenhao Huang, et al.. (2016). TGFβ signaling regulates the choice between pluripotent and neural fates during reprogramming of human urine derived cells. Scientific Reports. 6(1). 22484–22484. 17 indexed citations
14.
Wang, Lihui, et al.. (2016). Characterization and redox regulation ofPlasmodium falciparummethionine adenosyltransferase. The Journal of Biochemistry. 160(6). 355–367. 9 indexed citations
15.
Gao, Jing, Liya Zhou, Li Ma, et al.. (2016). Lipase Immobilization through the Combination of Bioimprinting and Cross-Linked Protein-Coated Microcrystal Technology for Biodiesel Production. Industrial & Engineering Chemistry Research. 55(42). 11037–11043. 23 indexed citations
16.
Wang, Lihui, et al.. (2015). Repair of a cervical skin defect using xenogeneic acellular dermal matrix in a patient with advanced laryngeal carcinoma. The Journal of Laryngology & Otology. 129(7). 715–717. 5 indexed citations
17.
Mao, Wei, Jin Dai, Qian Chen, et al.. (2015). Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model. Journal of Atherosclerosis and Thrombosis. 22(10). 1100–1112. 33 indexed citations
18.
Xu, Xiaoming, Wei Mao, Qian Chen, et al.. (2014). Endostar, a Modified Recombinant Human Endostatin, Suppresses Angiogenesis through Inhibition of Wnt/β-Catenin Signaling Pathway. PLoS ONE. 9(9). e107463–e107463. 49 indexed citations
19.
Wang, Lihui & Kai Li. (2008). The Anti-angiogenic and Anti-metastatic Effect of Endostatin on Lewis Lung Carcinoma Xenograft in Mice. 35(10). 1 indexed citations
20.
Zhang, Qingrong, et al.. (2000). Experimental verifications on chemical carcinogenesis, a bifunctional alkylation between DNA interstrands. Chinese Science Bulletin. 45(12). 1075–1079. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengwu Zhang Breakdown of academic impact, for papers by Alessandro Barberis Breakdown of academic impact, for papers by Monika Buríková Breakdown of academic impact, for papers by Dain Kim Breakdown of academic impact, for papers by Qisheng Luo Breakdown of academic impact, for papers by H-S Hsu Breakdown of academic impact, for papers by Zhengwei Leng Breakdown of academic impact, for papers by Jasdeep Chhina
Rankless by CCL
2026